|
|
Volumn 109, Issue 3, 2002, Pages 427-431
|
|
Human antitransforming growth factor β2 monoclonal antibody - A new modulator of wound healing in trabeculectomy: A randomized placebo controlled clinical study
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
MITOMYCIN C;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CAT 152;
PLACEBO;
TRANSFORMING GROWTH FACTOR BETA2;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG TOLERABILITY;
ENDOPHTHALMITIS;
FEMALE;
FOLLOW UP;
GLAUCOMA;
HUMAN;
HYPHEMA;
INTRAOCULAR PRESSURE;
MALE;
MUSCLE HYPOTONIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SCAR FORMATION;
SURGICAL WOUND;
TRABECULECTOMY;
UVEITIS;
VISUAL ACUITY;
WOUND HEALING;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL;
DRUG EVALUATION;
FEMALE;
GLAUCOMA;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
PROSPECTIVE STUDIES;
SAFETY;
TRABECULECTOMY;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
TREATMENT OUTCOME;
VISUAL ACUITY;
WOUND HEALING;
|
|
EID: 0036190919
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/S0161-6420(01)00997-6 Document Type: Article |
|
Times cited : (129)
|
|
References (32)
|
